Investing Profile

Alexandra Cantley

InvestorVC
Partner at Polaris Partners
Photo of Alexandra Cantley, Partner at Polaris Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
892 CONNECTIONS
Harvard University Network
146 CONNECTIONS
Polaris Partners Network
30 CONNECTIONS
Polaris Partners Network
30 CONNECTIONS
Polaris Venture Partners Network
24 CONNECTIONS
cb
$300K - $2.0M
$500K
8
$4B
CompanyStageDateRound SizeTotal Raised
TRex Bio
Series UnknownJan 2026$50M
Series BNov 2024$84M
Series AMar 2022$26M
$160M
EpiBiologics
Series BJan 2026$110M
Series AMar 2023$73M
$200M
Co-investors: Anika Gupta (GV (Google Ventures)), David Schenkein (GV (Google Ventures)), Samuel Bjork (Digitalis Ventures), Alaa Halawa (Mubadala), Gaurav Aggarwal (Vivo Capital), Nisa Leung (Qiming Venture Partners), Laura Brass (MPM BioImpact)
Auron Therapeutics
Series BFeb 2025$27M
Series AJul 2022$48M
$88M
Co-investors: Marianne Mertens (Apollo Health Ventures), Isaac Ciechanover (Qiming Venture Partners USA), Eric Shiozaki (Revelation Partners), Daniel Coley (Cofounders Capital)
Sunbird Bio
Series UnknownOct 2024$14M
$14M
Research technician Profesional independientePresent
Research technician Columbia UniversityPresent
Graduate Student Harvard UniversityPresent
Vertex Fellow Vertex PharmaceuticalsPresent
Scientist Inzen TherapeuticsPresent
Principal Polaris PartnersPresent
Principal Polaris Venture PartnersPresent
Board Member EpiBiologicsPresent
Board Member TRexBioPresent
Board Observer Capstan TherapeuticsPresent
Board Member Auron Therapeutics, Inc.Present
Board Member Crossbow Therapeutics, IncPresent
Board Member Cirrus TherapeuticsPresent
Board Member Amplifire eLearningPresent
Partner Polaris PartnersPresent
Partner Polaris Venture PartnersPresent
Harvard University Doctor of Philosophy (PhD) Chemical Biology
Sign in with Google →
Sign in with Google →